What The Broken Circle Breakdown Gets Right About Losing a Child to Cancer

In the 2012 Belgian film "The Broken Circle Breakdown," Didier and Elise fall in love over bluegrass music in Ghent. They build a life together and have a daughter, Maybelle. The film jumps back and forth in time. So the audience knows almost from the start that this happiness will not last. Shortly after her sixth birthday, Maybelle is diagnosed with cancer. Her health declines quickly, and she dies within about a year. What follows isn't really a medical story. It's a portrait of two parents who grieve in opposite directions. Didier retreats into science and rage. Elise turns to faith and reinvention. The gap between them becomes unbridgeable.

The film, directed by Felix van Groeningen, won the César Award for Best Foreign Film. It was Belgium's submission for the Academy Award for Best Foreign Language Film. Critics praised its raw, non-linear depiction of a marriage collapsing under grief. It never names Maybelle's specific cancer type or dwells on hospital detail. The illness stays in the background of the emotional wreckage it leaves behind. That choice makes the film powerful as drama. But it also means viewers looking for medical accuracy have to fill in a lot of blanks themselves.

How a diagnosis like Maybelle's actually gets worked up

Childhood cancer is, thankfully, rare. But when it happens, the emotional terrain the film depicts is recognizable to many families. A diagnosis in a previously healthy young child gets worked up much like adult cancer. Doctors use imaging, biopsy or bone marrow sampling depending on the suspected type, and blood work to see how far the disease has spread. That helps them pick which treatment protocol fits. Leukemias, brain tumors and lymphomas are the most common childhood cancers, followed by solid tumors like neuroblastoma or Wilms tumor. Each has its own staging system and treatment path. Pediatric oncologists typically manage care through specialized children's cancer centers. They use cooperative-group protocols refined over decades of research.

What the film gets right is the texture of the experience, not its clinical details. There's the fear that arrives with a diagnosis. The disruption to ordinary family life. The exhausting rhythm of waiting for scans and results. The physical toll of treatment. And the way caregiving strain can fracture even a strong relationship. Parents of children with cancer commonly describe exactly this kind of whiplash — normal life and hospital life colliding, with no good way to hold both at once. The film shows Didier and Elise unraveling in different directions, rather than uniting in shared purpose. That's more honest than the "grief brings people together" cliché many stories reach for.

The timeline the film compresses

The most significant simplification is the timeline itself. The film shows a child's cancer "quickly deteriorating" within about a year, from sudden onset to death. For many pediatric cancer types, the real course is longer and more uncertain. That course can include remission, relapse, and second-line treatment. Outcomes vary a lot by cancer type and stage at diagnosis. The film never says what type of cancer Maybelle has. So it's impossible to say whether her course is medically realistic for that disease. It works more as a narrative device than a case study.

It's also worth remembering that survival statistics describe populations, not individuals. Overall, pediatric cancer survival rates have improved a lot over the past several decades. Overall, five-year survival for childhood cancer is now above 80%. A single fictional child's story — especially one written to explore grief rather than illness — isn't representative of what most families experience. It shouldn't be read as a forecast for any real child's diagnosis.

Symptoms that look like ordinary childhood illness

Childhood cancers can show up in ways that are easy to mistake for ordinary childhood ailments. Watch for persistent unexplained fatigue, unexplained weight loss, a lump or swelling, easy bruising or unusual bleeding, bone or joint pain, recurring fevers, or changes in behavior or coordination. These symptoms overlap heavily with common, non-cancerous childhood illnesses. So most children who show one or more of them do not have cancer. That's exactly why persistent or worsening symptoms are worth a pediatrician's attention, not a reason for alarm on their own. They're the kind that don't resolve the way a normal cold or growing pain would.

Why there's no way to screen for it

There is no routine population-wide screening test for most childhood cancers, unlike the mammograms or colonoscopies used for some adult cancers. Families generally can't screen for childhood cancer or prevent it through lifestyle choices. Some risk is tied to inherited genetic syndromes. That's why children with a strong family history of cancer may be referred for genetic counseling. For families overall, general health measures matter for long-term health. That means avoiding tobacco exposure, limiting unnecessary radiation, and following pediatric care guidelines. But they can't guarantee a child will never develop cancer. When a childhood cancer does occur, early recognition of persistent symptoms and prompt evaluation remain the most meaningful things a family can control.

Stories like Maybelle's resonate because they put a face on statistics that can otherwise feel abstract. Families, teachers, and caregivers search for answers after a child's diagnosis. Keeping clear, accurate information available to them is part of why organizations like the National Cancer Information Foundation work to keep resources like this free and accessible to everyone who needs them.

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.